Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
Recursion Pharmaceuticals insiders completed 5 transactions: 3 stock sales totaling $268,602.34 and 2 stock awards with no reported value. All activity occurred between June and August 2026. Updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results